Tilman Todenhöfer

[Tilman Todenhöfer @ttodenhoefer]

@PGrivasMDPhD @shilpaonc @fredhutch Once EV Pembro are approved for 1st line mUC, I expect challenges to recruit patients in trials with IO mono arms (at least in regions where EV Pembro are available and reimbursed).

[IBCN @IBCN1997]

Congratulations to the winners of best abstract at #IBCN2023! Trine Strandgaard, Marie-Pier St-Laurent, and Joep de Jong. @LDyrskjot @pcvblack @mouwlab

[IBCN @IBCN1997]

📣 Reminder #IBCN23 9/28-30 in Montreal is fast approaching! Special 🙏 @WesKassouf @mcgillu and our expert speaker lineup for an outstanding program! @UroDocAsh @pcvblack @LDyrskjot @mouwlab @ttodenhoefer @Roland3097 @SWilliams_MD https://t.co/lWegGze76B

[Tilman Todenhöfer @ttodenhoefer]

@joostboormans @ErasmusMC @ChrisBangma @EMCUrolResearch Congratulations Joost. Well deserved!!!

[Tilman Todenhöfer @ttodenhoefer]

@ShuAkamats @AzadOncology @ResearchWyatt @urotoday @alkretsc_urol @drsfrees @PGrivasMDPhD I am wondering if "chemo-unfit" was introduced mainly for patients receiving NHA for mHSPC as I don't see a real relevance for patients receiving ADT only for mHSPC. Anyone aware of the proportion of patients in Propel who received NHA treatment before study participation?

[Tilman Todenhöfer @ttodenhoefer]

EU CHMP recommends approval of Olaparib/Abiraterone for first-line mCRPC treatment - Surprising as OS results are still immature. @AzadOncology @ResearchWyatt @urotoday @alkretsc_urol @drsfrees @PGrivasMDPhD

https://t.co/cFdEHNXPet

[IBCN @IBCN1997]

We are excited to host our annual meeting and the 25th Anniversary of @IBCN1997 in Barcelona, Spain this week September 29-October 1! Certain to be a meeting to remember! @UroDocAsh @pcvblack @LDyrskjot @ttodenhoefer @SWilliams_MD @GoebellJ @Roland3097 https://t.co/eSJm2C4QDV

[Rami Issa @Issarami]

#EAU22 early registration fee for a full member not including any courses or conference dinner is €1250, @Uroweb you must be jocking🙄

[Tilman Todenhöfer @ttodenhoefer]

@OfficeAme 🙏🙏... and all other authors for their excellent contributions!

[Tilman Todenhöfer @ttodenhoefer]

@OfficeAme 🙏@Roland3097 @je_bla @KilianGust @DrShariat Andres Schrader, @LuciaNappi4, Christian Kollmannsberger, Igor Tsaur, @SpiessPhilippe, @gb_schulz Morgan Roberts, Lukas Lunger, Isabell Heidegger

[Tilman Todenhöfer @ttodenhoefer]

@OfficeAme Thanks to @AzadOncology @declangmurphy @DKhalafMD Kim Chi @lawrentschuk @ShuAkamats Matthias Heck, Juergen Gschwend, @ProfHadaschik Kathrin Schlack, Martin Bögemann, Stefan Aufderklamm, @AStenzl, @ResearchWyatt, Nicolette Fonseca, @pcvblack, Vladin Koshkin, @PGrivasMDPhD

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

Brilliant summation of ctDNA in the clinic by @PGrivasMDPhD filling in at the nth hour today!

Building on work by @LDyrskjot @ResearchWyatt @tompowles1 @MattGalsky @sitcancer @IBCG_BladderCA @DSolit @scientistatlrge @ttodenhoefer @mouwlab & many others!

[IBCN @IBCN1997]

IBCN Webinar Series continues with another high impact presentation by @ResearchWyatt regarding ctDNA in metastatic setting! Powerhouse talks and impressive attendance with leaders in bladder cancer!

[Petros Grivas @PGrivasMDPhD]

Thanks @IBCN1997 for honoring invite to discuss insightful slides by the brilliant @MattGalsky it was a great session with @LDyrskjot @ResearchWyatt moderated by @ttodenhoefer thoughtful Q&A! Opportunities for scientific exchange & team learning! @pcvblack @UroDocAsh @shilpaonc

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

Join us for #1 of 3 #BladderCancer Updates

Kicking it off: @LDyrskjot @ResearchWyatt @MattGalsky @ttodenhoefer - on Sept 25th

Register here (free and for members): https://t.co/EGMY8Gdqed

@pcvblack @SWilliams_MD @PGrivasMDPhD @OncoAlert @IBCG_BladderCA @shilpaonc @pjhensley11

[Tilman Todenhöfer @ttodenhoefer]

Congratulations @pcvblack! Corresponding member of the German Association of Urology. Well deserved. #DGU2021

[Tilman Todenhöfer @ttodenhoefer]

@UroDocAsh @RSanchez_Salas @Uroweb @AmerUrological @UroCancerMD @MarekBabjuk @MariaJRibal @JamesJmm23 @rsybru @garysteinbergmd @bbmdmsk @WesKassouf @pcvblack @IBCG_BladderCA @SWilliams_MD @joanfundi @angiesmith_uro @MaxKates Agree 100%

[IBCN @IBCN1997]

📣We are excited to kick off our 2021 IBCN Update Series September 25,
1600-1730 CET ‘ctDNA and bladder cancer’ @ttodenhoefer @LDyrskjot @ResearchWyatt @MattGalsky. Open for members➡️inquire below to join, get info, meeting links, and more! https://t.co/vvatvk6tnZ

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

It’s here! #BladderCancer: a practical guide.
🌟 authors: @bbmdmsk @JoshMeeks @DrShariat @ahmostafid @MattGalsky @ArjunBalarMD @MRoupret @SpiessPhilippe @OncoBellmunt @Prof_Nick_James @BrantInman @PGrivasMDPhD @drphil_urology @AlisonBirtle

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

@KhurshidGuru @joanfundi @h_alahmadie @evacomperat @WesKassouf @siadaneshmand @RSanchez_Salas @WalterStadler5 @OLWMD @UrogerliMD @SWilliams_MD @bkonety @achoud72 @UroMoschini @saumyg @NateBrooksMD @AStenzl @ttodenhoefer